CytoDyn Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Equity Incentive Plan (Tables)

Equity Incentive Plan (Tables)

12 Months Ended

May 31, 2024

Equity Incentive Plan

Schedule of stock option activity


							Weighted
							average
				Weighted			remaining		Aggregate
		Number of		average			contractual		intrinsic
(in thousands, except per share data and years)		shares		exercise price			life in years		value
Options outstanding at May 31, 2022		17,457		$	1.53		7.79		$	—
Granted		12,417		$	0.41
Exercised		—		$	—
Forfeited, expired, and cancelled		(10,051)		$	1.16
Options outstanding at May 31, 2023		19,823		$	0.99		7.87		$	—
Granted		14,251		$	0.21
Exercised		—		$	—
Forfeited, expired, and cancelled		(8,225)		$	0.87
Options outstanding at May 31, 2024		25,849		$	0.60		7.77		$	—
Options outstanding and exercisable at May 31, 2024		19,679		$	0.71		7.25		$	—

Summary of fair values of stock options granted


		Years ended May 31,
		2024			2023
Expected Volatility		108.6% - 115.7	%		99.2% - 112.7	%
Weighted-Average Volatility		112.24	%		107.06	%
Expected Dividends		-	%		-	%
Expected Term (In years)		5.1 - 6.0			5.0 - 6.1
Risk-Free Rate		3.96	%		3.83	%

Schedule of Company RSU and PSU activity


							Weighted average
		Number of		Weighted average			remaining contractual
(shares in thousands)		RSUs and PSUs (1)		grant date fair value			life in years
Unvested RSUs and PSUs at May 31, 2022		300		$	3.12		0.58
RSUs and PSUs granted		1,293			0.58
RSUs and PSUs forfeited		(150)			3.12
RSUs and PSUs vested		(150)			3.12
Unvested RSUs and PSUs at May 31, 2023		1,293			0.58		0.81
RSUs and PSUs granted		—
RSUs and PSUs forfeited		(1,293)			0.58
RSUs and PSUs vested		—
Unvested RSUs and PSUs at May 31, 2024		—		$	—		—

(1)	The number of PSUs disclosed in this table are at the target level of 100%.